||Recombinant Human C3 (Accession # NP_000055) Ser672-Arg748 was produced in E. coli-derived.
|Predicted N Terminal:
||Lyophilized from a 0.2 µm filtered solution in PBS.
||Measured by its ability to enhance IL-6 secretion by human peripheral blood mononuclear cells (PBMC). Fischer, W.H. et al. (1999) J. Immunol. 162:453.The ED50 for this effect is typically 1.5 - 7.5 µg/mL.
||Recombinant Human C3 has a calculated MW of 9.1 kDa.
||>95%, by SDS-PAGE under reducing conditions and visualized by silver stain.
||Avoid repeated freeze-thaw cycles. No activity loss was observed after storage at: In lyophilized state for 1 year (4ºC); After reconstitution under sterile conditions for 3 months (-70ºC).